PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
172 hedge funds and large institutions have $3.48B invested in PRA Health Sciences, Inc. in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 34 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
64% more call options, than puts
Call options by funds: $1.92M | Put options by funds: $1.17M
34% more capital invested
Capital invested by funds: $2.6B → $3.48B (+$880M)
26% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 34
19% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 53
6% more funds holding
Funds holding: 163 → 172 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samlyn Capital
New York
|
+$26M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$19M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$14.9M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$14.9M |
| 5 |
Goldman Sachs
New York
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$128M |
| 2 |
Morgan Stanley
New York
|
-$16.7M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$11.2M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$10.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.82M |
PRAH Hedge Fund Activity: Q3 2016 in Review
172 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2016, worth a combined $3.48B — up 34% from $2.6B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new PRAH positions and 34 closed out — a net gain of 9 holders — while 63 added to existing stakes and 53 trimmed.
The largest buyer was Samlyn Capital, opening a new position worth an estimated $26M. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $128M sold.
- 172 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q3 2016, up from 163 in Q2 2016.
- Funds reported $3.48B of PRA Health Sciences, Inc. stock for Q3 2016, up 34% quarter-over-quarter.
- 43 funds opened new PRA Health Sciences, Inc. positions in Q3 2016 and 34 closed out, a net change of +9 holders.
- The largest PRA Health Sciences, Inc. buyer in Q3 2016 was Samlyn Capital, an estimated $26M added.
- The largest PRA Health Sciences, Inc. seller in Q3 2016 was Waddell & Reed Financial, an estimated $128M sold.
Based on aggregated 13F filings for Q3 2016.